Search results
3 days ago · Key Financial & Operating Results. Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023. Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 ...
2 days ago · USNA. -3.23%. USANA Health Sciences Inc . (NYSE: USNA) has reached a new 52-week low, with shares trading at $40.54. This marks a significant downturn for the company, which has seen its stock price steadily decline over the past year. The 52-week low of $40.54 is a stark contrast to the company's previous performance, indicating a challenging ...
3 days ago · USNA. SALT LAKE CITY, July 23, 2024 -- ( BUSINESS WIRE )--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024. Key ...
1 day ago · USNA. -3.20%. In the recent USANA Health Sciences (NYSE: USNA) Second Quarter Earnings Call, CEO Jim Brown and CFO Douglas Hekking shared insights into the company's strategic plans and performance. Amidst macroeconomic pressures, USANA is restructuring its commercial team, innovating products, and considering mergers and acquisitions (M&A) to ...
2 days ago · USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024. Key Financial & Operating Results Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023. Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 ...
2 days ago · USNA. -8.31%. USANA Health Sciences Inc . (NYSE: USNA) has reached a new 52-week low, with shares trading at $40.54. This marks a significant downturn for the company, which has seen its stock ...
3 days ago · USANA Health Sciences sees FY 2024 revenue of $850.00M-$880.00M versus the analyst consensus of $883.50M. USANA Health Sciences's stock price closed at $45.86. It is up 5.50% in the last 3 months and down -28.11% in the last 12 months. USANA Health Sciences saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days.
